Inhibitory effect of vitamin K1 on growth and polyamine biosynthesis of human gastric and colon carcinoma cell lines

Linsalata,Michele; Orlando,Antonella; Tutino,Valeria; Notarnicola,Maria; D'Attoma,Benedetta; Russo,Francesco

doi:10.3892/ijo.2015.3033

Inhibitory effect of vitamin K1 on growth and polyamine biosynthesis of human gastric and colon carcinoma cell lines

Authors:
- Michele Linsalata
- Antonella Orlando
- Valeria Tutino
- Maria Notarnicola
- Benedetta D'Attoma
- Francesco Russo
View Affiliations

Affiliations: Laboratory of Nutritional Pathophysiology, National Institute for Digestive Diseases, I.R.C.C.S. ‘Saverio de Bellis’, Castellana Grotte, 70013 Bari, Italy, Laboratory of Nutritional Biochemistry, National Institute for Digestive Diseases, I.R.C.C.S. ‘Saverio de Bellis’, Castellana Grotte, 70013 Bari, Italy
Published online on: June 4, 2015 https://doi.org/10.3892/ijo.2015.3033
Pages: 773-781

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric and colon cancers remain the leading cause of cancer mortality throughout the world. Since the gastrointestinal tract works in a constant link with the external environment, chemoprevention by dietary constituents could represent a possible approach to reduce cancer risk. Dietary vitamin K1 (VK1) has been shown to prevent the growth of many types of cancer cells. However, no data are available on possible different susceptibility to VK1 by gastric or colon neoplastic cell lines. Moreover, the exact mechanism of action of VK1 is still object of investigation, even if it has been reported that VK1 may induce cell cycle arrest and apoptosis. Therefore, molecules affecting cell growth such as the natural polyamines could be of interest in VK1 action. The aim of the present study was to investigate the effects of increasing concentrations of VK1 (from 10 to 200 µM) administered up to 72 h, on the cell proliferation and apoptosis of a gastric (HGC-27) and a colon (SW480) cancer cell line. Additionally, the polyamine biosynthesis and the MAPK pathway were also examined. VK1 treatments caused an inhibition of cell proliferation and an induction of apoptosis in both cell lines, with a concomitant significant decrease of the polyamine biosynthesis, increased phospho-ERK 1/2 expression was also observed. A different proliferative behavior and a different response to VK1 by gastric and colon cancer cells was evident, with colon cells showing a more pronounced susceptibility to VK1 action. VK1 is safe and without known toxicities in adult humans, consequently it could be effective in prevention and treatment of selected gastrointestinal neoplasms. Protocols based on the use of VK1, along with polyamine inhibitors and/or analogues, could represent a suitable alternative option for improving the efficacy of chemoprevention and treatment in future strategies for gastrointestinal cancer management.

View Figures

View References

1	Lepage C, Hamza S and Faivre J: Epidemiology and screening of colon cancer. Rev Prat. 60:1062–1067. 2010.(In French).
2	Milner JA, McDonald SS, Anderson DE and Greenwald P: Molecular targets for nutrients involved with cancer prevention. Nutr Cancer. 41:1–16. 2001.
3	MacFarlane AJ and Stover PJ: Convergence of genetic, nutritional and inflammatory factors in gastrointestinal cancers. Nutr Rev. 65:S157–S166. 2007. View Article : Google Scholar
4	Hitomi M, Yokoyama F, Kita Y, Nonomura T, Masaki T, Yoshiji H, Inoue H, Kinekawa F, Kurokohchi K, Uchida N, et al: Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. Int J Oncol. 26:713–720. 2005.PubMed/NCBI
5	Amalia H, Sasaki R, Suzuki Y, Demizu Y, Bito T, Nishimura H, Okamoto Y, Yoshida K, Miyawaki D, Kawabe T, et al: Vitamin K2-derived compounds induce growth inhibition in radioresistant cancer cells. Kobe J Med Sci. 56:E38–E49. 2010.PubMed/NCBI
6	Ogawa M, Nakai S, Deguchi A, Nonomura T, Masaki T, Uchida N, Yoshiji H and Kuriyama S: Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int J Oncol. 31:323–331. 2007.PubMed/NCBI
7	Lamson DW and Plaza SM: The anticancer effects of vitamin K. Altern Med Rev. 8:303–318. 2003.PubMed/NCBI
8	Shearer MJ and Newman P: Metabolism and cell biology of vitamin K. Thromb Haemost. 100:530–547. 2008.PubMed/NCBI
9	Yao Y, Li L, Zhang H, Jia R, Liu B, Zhao X, Zhang L, Qian G, Fan X and Ge S: Enhanced therapeutic efficacy of vitamin K2 by silencing BCL-2 expression in SMMC-7721 hepatocellular carcinoma cells. Oncol Lett. 4:163–167. 2012.PubMed/NCBI
10	Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG and Yamamoto K: Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Clin Cancer Res. 13:2236–2245. 2007. View Article : Google Scholar : PubMed/NCBI
11	Kanamori T, Shimizu M, Okuno M, Matsushima-Nishiwaki R, Tsurumi H, Kojima S and Moriwaki H: Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells. Cancer Sci. 98:431–437. 2007. View Article : Google Scholar : PubMed/NCBI
12	Du W, Zhou JR, Wang DL, Gong K and Zhang QJ: Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf/MEK/ERK pathway. World J Surg Oncol. 10:602012. View Article : Google Scholar : PubMed/NCBI
13	Showalter SL, Wang Z, Costantino CL, Witkiewicz AK, Yeo CJ, Brody JR and Carr BI: Naturally occurring K vitamins inhibit pancreatic cancer cell survival through a caspase-dependent pathway. J Gastroenterol Hepatol. 25:738–744. 2010. View Article : Google Scholar
14	Orlando A, Linsalata M, Tutino V, D’Attoma B, Notarnicola M and Russo F: Vitamin K1 exerts antiproliferative effects and induces apoptosis in three differently graded human colon cancer cell lines. BioMed Res Int. Article ID 296721 (In press).
15	Tokita H, Tsuchida A, Miyazawa K, Ohyashiki K, Katayanagi S, Sudo H, Enomoto M, Takagi Y and Aoki T: Vitamin K2-induced antitumor effects via cell-cycle arrest and apoptosis in gastric cancer cell lines. Int J Mol Med. 17:235–243. 2006.PubMed/NCBI
16	Kawakita H, Tsuchida A, Miyazawa K, Naito M, Shigoka M, Kyo B, Enomoto M, Wada T, Katsumata K, Ohyashiki K, et al: Growth inhibitory effects of vitamin K2 on colon cancer cell lines via different types of cell death including autophagy and apoptosis. Int J Mol Med. 23:709–716. 2009.PubMed/NCBI
17	Igarashi K and Kashiwagi K: Modulation of cellular function by polyamines. Int J Biochem Cell Biol. 42:39–51. 2010. View Article : Google Scholar
18	Moschou PN and Roubelakis-Angelakis KA: Polyamines and programmed cell death. J Exp Bot. 65:1285–1296. 2014. View Article : Google Scholar
19	Nowotarski SL, Woster PM and Casero RA Jr: Polyamines and cancer: implications for chemotherapy and chemoprevention. Expert Rev Mol Med. 22;15:e32013. View Article : Google Scholar : PubMed/NCBI
20	Ramani D, De Bandt JP and Cynober L: Aliphatic polyamines in physiology and diseases. Clin Nutr. 33:14–22. 2014. View Article : Google Scholar
21	Laukaitis CM and Gerner EW: DFMO: Targeted risk reduction therapy for colorectal neoplasia. Best Pract Res Clin Gastroenterol. 25:495–506. 2011. View Article : Google Scholar : PubMed/NCBI
22	Seiler N: Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect Part 1 Selective enzyme inhibitors. Curr Drug Targets. 4:537–564. 2003. View Article : Google Scholar : PubMed/NCBI
23	Linsalata M and Russo F: Nutritional factors and polyamine metabolism in colorectal cancer. Nutrition. 24:382–389. 2008. View Article : Google Scholar : PubMed/NCBI
24	Linsalata M, Orlando A, Messa C, Refolo MG and Russo F: Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesis. Anticancer Res. 30:3501–3507. 2010.PubMed/NCBI
25	Linsalata M, Cavallini A, Messa C, Orlando A, Refolo MG and Russo F: Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: A strategy toward nutritional approach to chemoprevention of gastric cancer. Curr Pharm Des. 16:847–853. 2010. View Article : Google Scholar
26	MacKeigan JP, Collins TS and Ting JP: MEK inhibition enhances paclitaxel-induced tumor apoptosis. J Biol Chem. 275:38953–38956. 2000. View Article : Google Scholar : PubMed/NCBI
27	Orlando A, Linsalata M, Notarnicola M, Tutino V and Russo F: Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines. BMC Microbiol. 14:192014. View Article : Google Scholar : PubMed/NCBI
28	Linsalata M, Notarnicola M, Tutino V, Bifulco M, Santoro A, Laezza C, Messa C, Orlando A and Caruso MG: Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. Anticancer Res. 30:2583–2589. 2010.PubMed/NCBI
29	Linsalata M, Russo F, Notarnicola M, Berloco P and Di Leo A: Polyamine profile in human gastric mucosa infected by Helicobacter pylori. Ital J Gastroenterol Hepatol. 30:484–489. 1998.PubMed/NCBI
30	Garewal HS, Sloan D, Sampliner RE and Fennerty B: Ornithine decarboxylase assay in human colorectal mucosa. Methodologic issues of importance to quality control. Int J Cancer. 52:355–358. 1992. View Article : Google Scholar : PubMed/NCBI
31	Kayashima T, Mori M, Yoshida H, Mizushina Y and Matsubara K: 1,4-Naphthoquinone is a potent inhibitor of human cancer cell growth and angiogenesis. Cancer Lett. 278:34–40. 2009. View Article : Google Scholar : PubMed/NCBI
32	Adnan H, Antenos M and Kirby GM: The effect of menadione on glutathione S-transferase A1 (GSTA1): c-Jun N-terminal kinase (JNK) complex dissociation in human colonic adenocarcinoma Caco-2 cells. Toxicol Lett. 214:53–62. 2012. View Article : Google Scholar : PubMed/NCBI
33	Wei G, Wang M and Carr BI: Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways. J Cell Physiol. 224:112–119. 2010.PubMed/NCBI
34	Wei G, Wang M, Hyslop T, Wang Z and Carr BI: Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo. Int J Cancer. 127:2949–2958. 2010. View Article : Google Scholar :
35	Gerner EW and Meyskens FL Jr: Polyamines and cancer: Old molecules, new understanding. Nat Rev Cancer. 4:781–792. 2004. View Article : Google Scholar : PubMed/NCBI
36	Casero RA Jr and Marton LJ: Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov. 6:373–390. 2007. View Article : Google Scholar : PubMed/NCBI
37	Pegg AE: Regulation of ornithine decarboxylase. J Biol Chem. 281:14529–14532. 2006. View Article : Google Scholar : PubMed/NCBI
38	Linsalata M, Orlando A and Russo F: Pharmacological and dietary agents for colorectal cancer chemoprevention: effects on polyamine metabolism (Review). Int J Oncol. 45:1802–1812. 2014.PubMed/NCBI
39	Deloyer P, Peulen O and Dandrifosse G: Dietary polyamines and non-neoplastic growth and disease. Eur J Gastroenterol Hepatol. 13:1027–1032. 2001. View Article : Google Scholar : PubMed/NCBI
40	Seiler N and Raul F: Polyamines and apoptosis. J Cell Mol Med. 9:623–642. 2005. View Article : Google Scholar : PubMed/NCBI
41	Davidson NE, Hahm HA, McCloskey DE, Woster PM and Casero RA Jr: Clinical aspects of cell death in breast cancer: The polyamine pathway as a new target for treatment. Endocr Relat Cancer. 6:69–73. 1999. View Article : Google Scholar
42	Gao JH, Guo LJ, Huang ZY, Rao JN and Tang CW: Roles of cellular polyamines in mucosal healing in the gastrointestinal tract. J Physiol Pharmacol. 64:681–693. 2013.
43	Sui X, Kong N, Ye L, Han W, Zhou J, Zhang Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett. 344:174–179. 2014. View Article : Google Scholar
44	Zhu L, Yu X, Akatsuka Y, Cooper JA and Anasetti C: Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells. Immunology. 97:26–35. 1999. View Article : Google Scholar : PubMed/NCBI
45	Osada S, Osada K and Carr BI: Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins. J Mol Biol. 314:765–772. 2001. View Article : Google Scholar : PubMed/NCBI
46	Manni A, Washington S, Hu X, Griffith JW, Bruggeman R, Demers LM, Mauger D and Verderame MF: Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells. Clin Exp Metastasis. 22:255–263. 2005. View Article : Google Scholar : PubMed/NCBI
47	Matsumoto K, Okano J, Nagahara T and Murawaki Y: Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition. Int J Oncol. 29:1501–1508. 2006.PubMed/NCBI
48	Duranton B, Holl V, Schneider Y, Carnesecchi S, Gossé F, Raul F and Seiler N: Polyamine metabolism in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). Amino Acids. 24:63–72. 2003.PubMed/NCBI
49	Mizuta T, Ozaki I, Eguchi Y, Yasutake T, Kawazoe S, Fujimoto K and Yamamoto K: The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study. Cancer. 106:867–872. 2006. View Article : Google Scholar : PubMed/NCBI